The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing duration of breakthrough chemotherapy-induced nausea and vomiting (CINV): A pooled study analysis of NEPA versus aprepitant.
 
Rudolph M. Navari
Research Funding - HERON (Inst)
Travel, Accommodations, Expenses - HERON
 
Gary Binder
Employment - Helsinn Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Helsinn Therapeutics
 
Erminio Bonizzoni
Consulting or Advisory Role - Adienne; Helsinn Healthcare; Roche; Zambon
 
Rebecca Clark-Snow
Consulting or Advisory Role - Helsinn Therapeutics; Heron
Speakers' Bureau - Merck
 
Silvia Olivari Tilola
Employment - Helsinn Healthcare
 
Eric Roeland
Consulting or Advisory Role - AIM Specialty Health; Asahi Kasei; Astellas Pharma; BASF; Helsinn Therapeutics; HERON; Napo Pharmaceuticals; Oragenics; Oragenics; Pfizer/EMD Serono; Vector Oncology
Expert Testimony - Regents of the University of California